New targets for NAFLD - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue JHEP Reports Innovation in Hepatology Année : 2021

New targets for NAFLD

Résumé

Non-alcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease worldwide. It is characterised by steatosis, liver inflammation, hepatocellular injury and progressive fibrosis. Several preclinical models (dietary and genetic animal models) of NAFLD have deepened our understanding of its aetiology and pathophysiology. Despite the progress made, there are currently no effective treatments for NAFLD. In this review, we will provide an update on the known molecular pathways involved in the pathophysiology of NAFLD and on ongoing studies of new therapeutic targets.
Fichier principal
Vignette du fichier
1-s2.0-S2589555921001221-main.pdf (1.16 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03472343 , version 1 (09-12-2021)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

Citer

Lucia Parlati, Marion Régnier, Hervé Guillou, Catherine Postic. New targets for NAFLD. JHEP Reports Innovation in Hepatology, 2021, 3 (6), pp.100346. ⟨10.1016/j.jhepr.2021.100346⟩. ⟨hal-03472343⟩
58 Consultations
182 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More